✦ LIBER ✦

Post hoc analysis of coronary findings from the prospective randomized evaluation of the vascular effects of the Norvasc trial (PREVENT)

✍ Scribed by G.B.John Mancini; Michael E Miller; Gregory W Evans; Robert Byington; Curt D Furberg; Bertram Pitt

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rationale, design, and baseline characte

✍ Robert P. Byington; Michael E. Miller; David Herrington; Ward Riley; Bertram Pit 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 533 KB

Coronary angiographic changes in patient

✍ G.B John Mancini; Bertram Pitt 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Effectiveness of Percutaneous Coronary I

✍ Gilbert Gosselin; Koon K. Teo; Jean-Francois Tanguay; Rohit Gokhale; Pamela M. H 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 644 KB

The relationship, structure and profiles

✍ Lei Chen; Glenn Phillips; Joseph Johnston; Bruce J Kinon; Haya Ascher-Svanum; Sa 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 301 KB

A prospective, randomized, double-blind,

📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 129 KB

Use of Nafamostat Mesilate and Gabexate

✍ Cheol Woong Choi; Dae Hwan Kang; Gwang-Ha Kim; Geun-Am Song; Jae-Sup Eum; Sang-Y 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 84 KB